Search Results - "Cohn, L"

The heterogeneity of cellular senescence: insights at the single-cell level by Cohn, Rachel L., Gasek, Nathan S., Kuchel, George A., Xu, Ming

“…Senescent cells are highly associated with aging and pathological conditions and could be targeted to slow the aging process. One commonly used marker to…”
Get full text

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group by Irwin, Meredith S, Naranjo, Arlene, Zhang, Fan F, Cohn, Susan L, London, Wendy B, Gastier-Foster, Julie M, Ramirez, Nilsa C, Pfau, Ruthann, Reshmi, Shalini, Wagner, Elizabeth, Nuchtern, Jed, Asgharzadeh, Shahab, Shimada, Hiroyuki, Maris, John M, Bagatell, Rochelle, Park, Julie R, Hogarty, Michael D

“…Treatment planning for children with neuroblastoma requires accurate assessment of prognosis. The most recent Children's Oncology Group (COG) risk…”
Get full text

Advances in Risk Classification and Treatment Strategies for Neuroblastoma by Pinto, Navin R, Applebaum, Mark A, Volchenboum, Samuel L, Matthay, Katherine K, London, Wendy B, Ambros, Peter F, Nakagawara, Akira, Berthold, Frank, Schleiermacher, Gudrun, Park, Julie R, Valteau-Couanet, Dominique, Pearson, Andrew D J, Cohn, Susan L

“…Risk-based treatment approaches for neuroblastoma have been ongoing for decades. However, the criteria used to define risk in various institutional and…”
Get full text

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children by Lewinsohn, David M., Leonard, Michael K., LoBue, Philip A., Cohn, David L., Daley, Charles L., Desmond, Ed, Keane, Joseph, Lewinsohn, Deborah A., Loeffler, Ann M., Mazurek, Gerald H., O'Brien, Richard J., Pai, Madhukar, Richeldi, Luca, Salfinger, Max, Shinnick, Thomas M., Sterling, Timothy R., Warshauer, David M., Woods, Gail L.

“…Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical…”
Get full text

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children by Lewinsohn, David M, Leonard, Michael K, LoBue, Philip A, Cohn, David L, Daley, Charles L, Desmond, Ed, Keane, Joseph, Lewinsohn, Deborah A, Loeffler, Ann M, Mazurek, Gerald H, O'Brien, Richard J, Pai, Madhukar, Richeldi, Luca, Salfinger, Max, Shinnick, Thomas M, Sterling, Timothy R, Warshauer, David M, Woods, Gail L

“…Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of…”
Get full text

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting by Park, Julie R, Bagatell, Rochelle, Cohn, Susan L, Pearson, Andrew D, Villablanca, Judith G, Berthold, Frank, Burchill, Susan, Boubaker, Ariane, McHugh, Kieran, Nuchtern, Jed G, London, Wendy B, Seibel, Nita L, Lindwasser, O Wolf, Maris, John M, Brock, Penelope, Schleiermacher, Gudrun, Ladenstein, Ruth, Matthay, Katherine K, Valteau-Couanet, Dominique

“…Purpose More than two decades ago, an international working group established the International Neuroblastoma Response Criteria (INRC) to assess treatment…”
Get full text

Neuroblastoma by Maris, John M, MD, Hogarty, Michael D, MD, Bagatell, Rochelle, MD, Cohn, Susan L, Prof

“…Summary The clinical hallmark of neuroblastoma is heterogeneity, with the likelihood of cure varying widely according to age at diagnosis, extent of disease,…”
Get full text

Children's Oncology Group's 2013 blueprint for research: Neuroblastoma by Park, Julie R., Bagatell, Rochelle, London, Wendy B., Maris, John M., Cohn, Susan L., Mattay, Katherine M., Hogarty, Michael

“…Estimated 5‐year survival rates for patients with non‐high‐risk and high‐risk neuroblastoma are 90% and 50%, respectively. Recent clinical trials have shown…”
Get full text

Modulation of matrix remodeling by SPARC in neoplastic progression by Chlenski, Alexandre, Cohn, Susan L.

“…SPARC is a matricellular glycoprotein that mediates interactions between cells and their microenvironment. It is produced at sites of tissue remodeling, where…”
Get full text

Epidemiological data from the COVID-19 outbreak, real-time case information by Xu, Bo, Gutierrez, Bernardo, Mekaru, Sumiko, Sewalk, Kara, Goodwin, Lauren, Loskill, Alyssa, Cohn, Emily L., Hswen, Yulin, Hill, Sarah C., Cobo, Maria M., Zarebski, Alexander E., Li, Sabrina, Wu, Chieh-Hsi, Hulland, Erin, Morgan, Julia D., Wang, Lin, O’Brien, Katelynn, Scarpino, Samuel V., Brownstein, John S., Pybus, Oliver G., Pigott, David M., Kraemer, Moritz U. G.

“…Cases of a novel coronavirus were first reported in Wuhan, Hubei province, China, in December 2019 and have since spread across the world. Epidemiological…”
Get full text

Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project by Sokol, Elizabeth, Desai, Ami V, Applebaum, Mark A, Valteau-Couanet, Dominique, Park, Julie R, Pearson, Andrew D J, Schleiermacher, Gudrun, Irwin, Meredith S, Hogarty, Michael, Naranjo, Arlene, Volchenboum, Samuel, Cohn, Susan L, London, Wendy B

“…The Children's Oncology Group (COG) stratifies the treatment of patients with neuroblastoma on the basis of a combination of biomarkers that include age and…”
Get full text

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report by COHN, Susan L, PEARSON, Andrew D. J, MOSSERI, Veronique, SIMON, Thorsten, GARAVENTA, Alberto, CASTEL, Victoria, MATTHAY, Katherine K, LONDON, Wendy B, MONCLAIR, Tom, AMBROS, Peter F, BRODEUR, Garrett M, FALDUM, Andreas, HERO, Barbara, IEHARA, Tomoko, MACHIN, David

“…Because current approaches to risk classification and treatment stratification for children with neuroblastoma (NB) vary greatly throughout the world, it is…”
Get full text

An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy by Saukkonen, Jussi J, Cohn, David L, Jasmer, Robert M, Schenker, Steven, Jereb, John A, Nolan, Charles M, Peloquin, Charles A, Gordin, Fred M, Nunes, David, Strader, Dorothy B, Bernardo, John, Venkataramanan, Raman, Sterling, Timothy R, on behalf of ATS Hepatotoxicity of Antituberculosis Therapy Subcommittee

“…Drug-induced liver injury (DILI) is a problem of increasing significance, but has been a long-standing concern in the treatment of tuberculosis (TB) infection…”
Get full text

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project by Vo, Kieuhoa T, Matthay, Katherine K, Neuhaus, John, London, Wendy B, Hero, Barbara, Ambros, Peter F, Nakagawara, Akira, Miniati, Doug, Wheeler, Kate, Pearson, Andrew D J, Cohn, Susan L, DuBois, Steven G

“…Neuroblastoma (NB) is a heterogeneous tumor arising from sympathetic tissues. The impact of primary tumor site in influencing the heterogeneity of NB remains…”
Get full text

TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma by Mariani, Christopher J., Vasanthakumar, Aparna, Madzo, Jozef, Yesilkanal, Ali, Bhagat, Tushar, Yu, Yiting, Bhattacharyya, Sanchari, Wenger, Roland H., Cohn, Susan L., Nanduri, Jayasri, Verma, Amit, Prabhakar, Nanduri R., Godley, Lucy A.

“…The ten-eleven-translocation 5-methylcytosine dioxygenase (TET) family of enzymes catalyzes the conversion of 5-methylcytosine (5-mC) to…”
Get full text

Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project by LONDON, Wendy B, CASTEL, Victoria, MATTHAY, Katherine K, MONCLAIR, Tom, AMBROS, Peter F, PEARSON, Andrew D. J, COHN, Susan L, BERTHOLD, Frank, NAKAGAWARA, Akira, LADENSTEIN, Ruth L, IEHARA, Tomoko

“…Survival after neuroblastoma relapse is poor. Understanding the relationship between clinical and biologic features and outcome after relapse may help in…”
Get full text

The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report by MONCLAIR, Tom, BRODEUR, Garrett M, VON SCHWEINITZ, Dietrich, SIMON, Thorsten, COHN, Susan L, PEARSON, Andrew D. J, AMBROS, Peter F, BRISSE, Hervé J, CECCHETTO, Giovanni, HOLMES, Keith, KANEKO, Michio, LONDON, Wendy B, MATTHAY, Katherine K, NUCHTERN, Jed G

“…The International Neuroblastoma Risk Group (INRG) classification system was developed to establish a consensus approach for pretreatment risk stratification…”
Get full text

Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project by BRISSE, Hervé J, MCCARVILLE, M. Beth, LEWINGTON, Valerie J, SARNACKI, Sabine, HERO, Barbara, KANEKO, Michio, LONDON, Wendy B, PEARSON, Andrew D. J, COHN, Susan L, MONCLAIR, Tom, GRANATA, Claudio, BARBARA KRUG, K, WOOTTON-GORGES, Sandra L, KANEGAWA, Kimio, GIAMMARILE, Francesco, SCHMIDT, Matthias, SHULKIN, Barry L, MATTHAY, Katherine K

“…Neuroblastoma is an enigmatic disease entity; some tumors disappear spontaneously without any therapy, while others progress with a fatal outcome despite the…”
Get full text

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project by Schleiermacher, G, Mosseri, V, London, W B, Maris, J M, Brodeur, G M, Attiyeh, E, Haber, M, Khan, J, Nakagawara, A, Speleman, F, Noguera, R, Tonini, G P, Fischer, M, Ambros, I, Monclair, T, Matthay, K K, Ambros, P, Cohn, S L, Pearson, A D J

“…Background: In the INRG dataset, the hypothesis that any segmental chromosomal alteration might be of prognostic impact in neuroblastoma without MYCN…”
Get full text

Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men by Wilkin, Timothy, Lee, Jeannette Y., Lensing, Shelly Y., Stier, Elizabeth A., Goldstone, Stephen E., Berry, J. Michael, Jay, Naomi, Aboulafia, David, Cohn, David L., Einstein, Mark H., Saah, Alfred, Mitsuyasu, Ronald T., Palefsky, Joel M.

“…Background. Human immunodeficiency virus type 1 (HIV-1)-infected men are at increased risk for anal cancer. Human papillomavirus (HPV) vaccination may prevent…”
Get full text